- call +1-201-465-4211
- email sales@mrinsights.biz
Drugs used for oncology.
Scope of the Report:
The worldwide market for Oncology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Oncology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck & Co.
Sanofi
Amgen Inc.
Abbvie, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Market Segment by Applications, can be divided into
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer
There are 15 Chapters to deeply display the global Oncology Drug market.
Chapter 1, to describe Oncology Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oncology Drug, with sales, revenue, and price of Oncology Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oncology Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oncology Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oncology Drug Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 gastrointestinal Tract Cancer
1.3.4 Prostate Cancer
1.3.5 Lung Cancer
1.3.6 Skin Cancer
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche Ltd
2.1.1 Business Overview
2.1.2 Oncology Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Ltd Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Oncology Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bristol-Myers Squibb
2.3.1 Business Overview
2.3.2 Oncology Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bristol-Myers Squibb Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celgene Corporation
2.4.1 Business Overview
2.4.2 Oncology Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celgene Corporation Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Oncology Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pfizer Inc.
2.6.1 Business Overview
2.6.2 Oncology Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Inc. Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Astra Zenca Plc
2.7.1 Business Overview
2.7.2 Oncology Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Astra Zenca Plc Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly And Company.
2.8.1 Business Overview
2.8.2 Oncology Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly And Company. Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Glaxosmithkline Plc
2.9.1 Business Overview
2.9.2 Oncology Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Glaxosmithkline Plc Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck & Co.
2.10.1 Business Overview
2.10.2 Oncology Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck & Co. Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Sanofi
2.11.1 Business Overview
2.11.2 Oncology Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sanofi Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Amgen Inc.
2.12.1 Business Overview
2.12.2 Oncology Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Amgen Inc. Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Abbvie, Inc.
2.13.1 Business Overview
2.13.2 Oncology Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Abbvie, Inc. Oncology Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncology Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oncology Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oncology Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Oncology Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oncology Drug Market Analysis by Regions
4.1 Global Oncology Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oncology Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Oncology Drug Sales and Growth Rate (2013-2018)
4.3 Europe Oncology Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncology Drug Sales and Growth Rate (2013-2018)
4.5 South America Oncology Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncology Drug Sales and Growth Rate (2013-2018)
5 North America Oncology Drug by Countries
5.1 North America Oncology Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Oncology Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oncology Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Oncology Drug Sales and Growth Rate (2013-2018)
5.3 Canada Oncology Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Oncology Drug Sales and Growth Rate (2013-2018)
6 Europe Oncology Drug by Countries
6.1 Europe Oncology Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Oncology Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oncology Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oncology Drug Sales and Growth Rate (2013-2018)
6.3 UK Oncology Drug Sales and Growth Rate (2013-2018)
6.4 France Oncology Drug Sales and Growth Rate (2013-2018)
6.5 Russia Oncology Drug Sales and Growth Rate (2013-2018)
6.6 Italy Oncology Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oncology Drug by Countries
7.1 Asia-Pacific Oncology Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oncology Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oncology Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Oncology Drug Sales and Growth Rate (2013-2018)
7.3 Japan Oncology Drug Sales and Growth Rate (2013-2018)
7.4 Korea Oncology Drug Sales and Growth Rate (2013-2018)
7.5 India Oncology Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oncology Drug Sales and Growth Rate (2013-2018)
8 South America Oncology Drug by Countries
8.1 South America Oncology Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Oncology Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oncology Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oncology Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Oncology Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Oncology Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oncology Drug by Countries
9.1 Middle East and Africa Oncology Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oncology Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oncology Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oncology Drug Sales and Growth Rate (2013-2018)
9.3 UAE Oncology Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Oncology Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Oncology Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Oncology Drug Sales and Growth Rate (2013-2018)
10 Global Oncology Drug Market Segment by Type
10.1 Global Oncology Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oncology Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Oncology Drug Revenue and Market Share by Type (2013-2018)
10.2 Chemotherapy Sales Growth and Price
10.2.1 Global Chemotherapy Sales Growth (2013-2018)
10.2.2 Global Chemotherapy Price (2013-2018)
10.3 Targeted Therapy Sales Growth and Price
10.3.1 Global Targeted Therapy Sales Growth (2013-2018)
10.3.2 Global Targeted Therapy Price (2013-2018)
10.4 Immunotherapy Sales Growth and Price
10.4.1 Global Immunotherapy Sales Growth (2013-2018)
10.4.2 Global Immunotherapy Price (2013-2018)
10.5 Hormonal Therapy Sales Growth and Price
10.5.1 Global Hormonal Therapy Sales Growth (2013-2018)
10.5.2 Global Hormonal Therapy Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Oncology Drug Market Segment by Application
11.1 Global Oncology Drug Sales Market Share by Application (2013-2018)
11.2 Blood Cancer Sales Growth (2013-2018)
11.3 Breast Cancer Sales Growth (2013-2018)
11.4 gastrointestinal Tract Cancer Sales Growth (2013-2018)
11.5 Prostate Cancer Sales Growth (2013-2018)
11.6 Lung Cancer Sales Growth (2013-2018)
11.7 Skin Cancer Sales Growth (2013-2018)
12 Oncology Drug Market Forecast (2018-2023)
12.1 Global Oncology Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Oncology Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Oncology Drug Market Forecast (2018-2023)
12.2.2 Europe Oncology Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oncology Drug Market Forecast (2018-2023)
12.2.4 South America Oncology Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oncology Drug Market Forecast (2018-2023)
12.3 Oncology Drug Market Forecast by Type (2018-2023)
12.3.1 Global Oncology Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Oncology Drug Market Share Forecast by Type (2018-2023)
12.4 Oncology Drug Market Forecast by Application (2018-2023)
12.4.1 Global Oncology Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Oncology Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oncology Drug Picture
Table Product Specifications of Oncology Drug
Figure Global Sales Market Share of Oncology Drug by Types in 2017
Table Oncology Dr
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
